SCHEMBL23577488

SCHEMBL23577488

O=C(O)COC1(c2ccc(C(=O)N3CCC(c4ccc(C(F)(F)F)cc4)CC3)cc2)COC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 2/20 0.47
▸ GAA P10253 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ CNR1 P21554 1/20 0.43
▸ HSD11B1 P28845 2/20 0.43
▸ MGLL Q99685 1/20 0.42
▸ EPHX2 P34913 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAPK7 Q13164 1/20 0.42
▸ FASN P49327 4/20 0.42
▸ TEAD1 P28347 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ PARP10 Q53GL7 1/20 0.40
▸ SLC9A1 P19634 1/20 0.40
▸ CHRM2 P08172 1/20 0.39
▸ CHRM5 P08912 1/20 0.39
▸ CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23577508 0.90 GAA (0.46) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577764 0.89 GAA (0.45) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577378 0.89 GAA (0.45) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577479 0.87 GAA (0.43) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577904 0.87 GAA (0.46) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577339 0.86 MAPK7 (0.48) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577492 0.85 EGLN1 (0.42) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL28818495 0.85 GAA (0.47) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577778 0.84 GAA (0.41) EGLN1GAATDP1CNR1HSD11B1
SCHEMBL23577850 0.84 CNR1 (0.44) EGLN1GAATDP1CNR1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN claimed
WO-2021130723-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA CADILA HEALTHCARE LIMITED (IN) 2021-07-01 — — WO claimed
EP-4081509-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA Zydus Lifesciences Limited (IN) 2022-11-02 — — EP disclosed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN disclosed
WO-2021130723-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA CADILA HEALTHCARE LIMITED (IN) 2021-07-01 — — WO disclosed
WO-2021130723-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA CADILA HEALTHCARE LIMITED (IN) 2021-07-01 — — WO disclosed
Send feedback